This is an exclusive BHB+ story Clinician retention challenges in addiction treatment arise when daily duties diverge from the essential mission of providing care. The addiction treatment industry now has the opportunity to bring innovation to bear on perennial challenges in ways previously unimaginable. The advent and seemingly overnight proliferation of AI-backed software and the […]
President Donald Trump signed the SUPPORT for Patients and Communities Reauthorization Act of 2025 into law on Dec. 1, reauthorizing substance use disorder (SUD) prevention, treatment and recovery programs through fiscal year 2030. First passed in 2018, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act established these […]
This is an exclusive BHB+ story AI may be dominating the zeitgeist around changes in mental health care. Yet, novel virtual reality (VR) techniques are emerging with strong evidence-based outcomes, and the combination of AI and VR could advance treatments if reimbursement catches up. VR’s use cases range from exposure therapy treatments for mild phobias […]
Behavioral health and addiction treatment providers are expecting renewed guidance from the Drug Enforcement Administration (DEA) around telehealth prescribing flexibilities for controlled substances, now that the longest government shutdown in the country’s history has been resolved. A pending executive order sent to the Office of Management and Budget titled “Fourth Temporary Extension of COVID-19 Telemedicine […]
This is an exclusive BHB+ story Harm reduction services could face new funding challenges as the practice loses favor with the federal government. Questions surrounding federal support for substance use disorder (SUD) treatment compounded after the Trump administration consolidated the Substance Abuse and Mental Health Services Administration (SAMHSA) into a new entity. Shortly after, the […]
While deals in the substance use disorder treatment space have been slow over the past year, addiction provider Crossroads has had an eye on growth. Over the summer, the company completed a tuck-in acquisition of Family Health Services, expanding its reach in the Pennsylvania market. Today, the provider has more than 100 centers across nine […]
Ethema Health Corporation (OTCQB: GRST), a provider of behavioral health and substance use disorder (SUD) services, plans to acquire Addiction Recovery Care LLC, a company that has been under FBI scrutiny for health care fraud in recent years. Combined revenue from the acquired assets could reportedly exceed $100 million in 2026 alone. Ethema plans to […]
Medicare could have saved $301.5 million if bundled payments for opioid use disorder (OUD) treatments were better matched to the services actually provided to patients. That’s equivalent to 53% of the total payments in this space of $564.6 million, according to an audit by the Office of Inspector General (OIG). For the audit, the OIG […]
Diagnoses of opioid use disorders (OUDs) have climbed 40% in commercially insured patients since 2021, according to new data from the nonprofit FAIR Health. FAIR Health is an independent data-focused organization that manages the nation’s largest database of privately billed health insurance claims. Patients between 31 and 40 years old had the highest percentage of […]
Ashley Addiction Treatment has raised $17 million as part of a $20 million capital campaign to fund new research efforts and expand programming. The campaign focuses on four priorities: a new research facility, renovations and upgrades to existing facilities, expanding family programs and providing treatment scholarships. The new research facility, dubbed Namvary Research Building, will […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
